Location: Home > Pharma China Web Edition
  • search
  • go
  • News in Focus
  • 12/11/2025Chinese Biopharma Sector Posts 22 Financings in November as In Vivo C...
  • 12/11/2025China Tightens Oversight as Domestic Innovators Dominate November Drug...
  • 12/9/2025Global Pharmas Turn to China Not Just for Assets, but for a New R&D Pl...
  • 12/2/2025China Launches National Drug Price Registration System to Propel Marke...
  • 12/2/2025NHC Releases 2024 China Health Statistics Bulletin
  • 12/1/2025MNC's County-Level Ambitions Falter as Strategies Shift From Heavy Inv...
  • 11/28/2025LEK: China's Clinical Trial Sector Enters a New Phase of Innovation an...
  • 11/27/2025MC's China Biopharma Tracker: Dealmaking, Approvals, and $451 Million ...
  • 11/21/2025China's Biopharma Innovation Surges — McKinsey Lays Out Both Opportun...
  • 11/21/2025US Report Flags Risks From China's Expanding Control of Pharma Supply ...
  • 11/20/2025China's Innovation-drug BD Boom Slows as Investors Shift Focus to Prod...
  • 11/18/2025China's October Approvals Signal the Next Five Years of Translational ...
  • 11/18/2025China Biopharma Strikes Record USD 19.9 B in Licensing Deals in Octobe...
  • 11/14/2025MNCs Face Diverging Fortunes and Strategic Reset in China
  • 11/14/2025Review of China's Late-Stage Global Innovative Drug Pipeline in 2025
  • 11/5/2025China Wraps Up 2025 Drug Negotiation: Dual Catalogs Debut, Innovative ...
  • 11/5/2025MNCs Retreat as China Cancels Dozens of Branded Medicines Amid Price C...
  • 11/5/2025Bloomberg: China Has Another Trade Weapon Waiting for America — Pharm...
  • 10/31/2025China's Biotech Deal Boom Tests Ethical Boundaries as Valuations Soar ...
  • 10/29/2025China Pushes Ethical Limits in Global Biotech Race With Gene-Edited An...
  • 10/21/2025ESMO 2025 Highlights China's Strategic Leap in Oncology Innovation
  • 10/13/2025U.S. Senate Approves Revised China Biotech Competition Bill with Softe...
  • 10/13/2025China's Innovative Drug Sector Secures Over CNY 4.2B in Q3 Financing, ...
  • 9/22/2025China's Role in Global Drug Approvals Expands as Regulatory Timelines ...
  • 9/19/2025​​​​​​​China Biopharma at Crossroads: A Mid-2025 Tale of Contra...
  • 9/19/2025Gottlieb Cautions Blanket China Drug Licensing Ban amid Calls for Rigo...
  • 9/2/2025China's Clinical Trial Quality Management Faces Key Challenges Despite...
  • 8/27/2025AstraZeneca Bounces Back from Scandal in China with $2.5B R&D Push
  • 8/27/2025Global Pharma Funnels $48.5B into Chinese Biotech Partnerships in H120...
  • 8/22/2025Premier Li Visits BeOne, Signaling China's Strategic Push for Biotech ...
  • Page:1/2 Total number of articles:38: [First][<<] [1] [2] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group